Conditions: Major Depressive Disorder
Keywords: depression major depressive disorder Alkermes ALKS 5461 samidorphan buprenorphine
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 66
Healthy volunteers: no

Brief summary:
This is a Phase 3 study designed to evaluate the safety and tolerability of two titration schedules for ALKS 5461.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: ALKS 5461
Intervention descriptions: intervention 1: Sublingual tablet taken once daily

Protocol document: